The global cell culture market size is expected to reach USD 63.12 billion by 2034, according to a new study by Polaris Market Research. The report “Cell Culture Market Share, Size, Trends, Industry Analysis Report: By Product (Consumables and Instruments), By Application, By End Use, and By Region – Market Forecast 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Cell culture is a laboratory method for cultivating cells in controlled environments. These cells serve multiple purposes, including drug testing, disease diagnosis, and scientific research. The market is expanding due to increased R&D in areas such as monoclonal antibodies. This is due to the rising prevalence of chronic illnesses such as cardiovascular diseases and autoimmune disorders. The demand for cell culture techniques is increasing, as gene therapies for cancer and neurological disorders require specialized media. The cell culture market is growing through advancements that combine nanofibers with cell culture media. The market is also expanding as small-scale biopharmaceutical companies adopt single-use processing methods, offering affordable, effective production solutions.
The cell culture market is seeing increased adoption of 3D cell culture models because they provide a more in vivo-like environment than 2D models. The models demonstrate better cell growth and differentiation, as well as improved responsiveness to stimuli, making them suitable for drug discovery, toxicity testing, and cancer research. Researchers now use 3D cultures because they provide better, more realistic data, while 3D models are becoming vital for personalized medicine, which develops therapies tailored to individual patients. New technologies, including scaffolding and bioprinting, support the development of 3D cell culture systems.
The consumables segment, by product, held a larger share of the cell culture market in 2025. This is due to its use in biopharmaceutical companies, academic research, and contract research institutes. The diagnostics segment, by application, is expected to experience the highest growth rate during the forecast period. The increasing use of cell cultures in metabolomics to identify biomarkers associated with various pathologically significant conditions is contributing to the segment’s growth.
A few key global market players include Sartorius AG; Danaher; Merck KGaA; Thermo Fisher Scientific, Inc.; Corning Inc.; Avantor, Inc.; BD; Eppendorf SE; Bio-Techne; and PromoCell GmbH.
The expanding use of gene therapies and advancements in cell culture techniques are driving market growth. The market is expected to develop as biotech and pharmaceutical firms advance medical research and innovation. North America led the global market in 2025. The rising prevalence of chronic diseases in the aging population and technological advancements in biopharmaceutical centers are contributing to the regional market dominance. The Asia Pacific cell culture market is anticipated to grow at a robust CAGR during the forecast period, driven by rising healthcare expenditure, increased awareness of cell and gene therapies, and vast opportunities in clinical research.
Request a free sample copy or read the full market insights: Cell Culture Market